These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 22842791)

  • 1. Behavioral, neurochemical and pharmaco-EEG profiles of the psychedelic drug 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in rats.
    Páleníček T; Fujáková M; Brunovský M; Horáček J; Gorman I; Balíková M; Rambousek L; Syslová K; Kačer P; Zach P; Bubeníková-Valešová V; Tylš F; Kubešová A; Puskarčíková J; Höschl C
    Psychopharmacology (Berl); 2013 Jan; 225(1):75-93. PubMed ID: 22842791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurochemical and behavioral differences between d-methamphetamine and d-amphetamine in rats.
    Shoblock JR; Sullivan EB; Maisonneuve IM; Glick SD
    Psychopharmacology (Berl); 2003 Feb; 165(4):359-69. PubMed ID: 12491026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rat strain differences in the ability to disrupt sensorimotor gating are limited to the dopaminergic system, specific to prepulse inhibition, and unrelated to changes in startle amplitude or nucleus accumbens dopamine receptor sensitivity.
    Kinney GG; Wilkinson LO; Saywell KL; Tricklebank MD
    J Neurosci; 1999 Jul; 19(13):5644-53. PubMed ID: 10377370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 4-Bromo-2,5-dimethoxyphenethylamine (2C-B): presence in the recreational drug market in Spain, pattern of use and subjective effects.
    Caudevilla-Gálligo F; Riba J; Ventura M; González D; Farré M; Barbanoj MJ; Bouso JC
    J Psychopharmacol; 2012 Jul; 26(7):1026-35. PubMed ID: 22234927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of chronic electroconvulsive shock on interstitial concentrations of dopamine in the nucleus accumbens.
    Nomikos GG; Zis AP; Damsma G; Fibiger HC
    Psychopharmacology (Berl); 1991; 105(2):230-8. PubMed ID: 1724565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amphetamine, cocaine, and fencamfamine: relationship between locomotor and stereotypy response profiles and caudate and accumbens dopamine dynamics.
    Kuczenski R; Segal DS; Aizenstein ML
    J Neurosci; 1991 Sep; 11(9):2703-12. PubMed ID: 1715389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine depletion of the nucleus accumbens reverses isolation-induced deficits in prepulse inhibition in rats.
    Powell SB; Geyer MA; Preece MA; Pitcher LK; Reynolds GP; Swerdlow NR
    Neuroscience; 2003; 119(1):233-40. PubMed ID: 12763084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of age on dopamine release in the nucleus accumbens and amphetamine-induced locomotor activity in rats.
    Huang RL; Wang CT; Tai MY; Tsai YF; Peng MT
    Neurosci Lett; 1995 Nov; 200(1):61-4. PubMed ID: 8584268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neonatal hippocampal lesions induced hyperresponsiveness to amphetamine: behavioral and in vivo microdialysis studies.
    Wan RQ; Giovanni A; Kafka SH; Corbett R
    Behav Brain Res; 1996 Aug; 78(2):211-23. PubMed ID: 8864054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amphetamine-induced neurochemical and locomotor responses are expressed differentially across the anteroposterior axis of the core and shell subterritories of the nucleus accumbens.
    Heidbreder C; Feldon J
    Synapse; 1998 Aug; 29(4):310-22. PubMed ID: 9661249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of amperozide on psychostimulant-induced hyperlocomotion and dopamine release in the nucleus accumbens.
    Kimura K; Nomikos GG; Svensson TH
    Pharmacol Biochem Behav; 1993 Jan; 44(1):27-36. PubMed ID: 7679220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of ((-)-2-oxa-4-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY379268), an mGlu2/3 receptor agonist, on EEG power spectra and coherence in ketamine model of psychosis.
    Fujáková M; Páleníček T; Brunovský M; Gorman I; Tylš F; Kubešová A; Řípová D; Krajča V; Horáček J
    Pharmacol Biochem Behav; 2014 Jul; 122():212-21. PubMed ID: 24631484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic desipramine enhances amphetamine-induced increases in interstitial concentrations of dopamine in the nucleus accumbens.
    Nomikos GG; Damsma G; Wenkstern D; Fibiger HC
    Eur J Pharmacol; 1991 Mar; 195(1):63-73. PubMed ID: 2065713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine autoreceptors in rat nucleus accumbens modulate prepulse inhibition of acoustic startle.
    Yamada S; Harano M; Tanaka M
    Pharmacol Biochem Behav; 1998 Aug; 60(4):803-8. PubMed ID: 9700961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-NMDA excitatory amino acid receptors in the ventral tegmental area mediate systemic dizocilpine (MK-801) induced hyperlocomotion and dopamine release in the nucleus accumbens.
    Mathé JM; Nomikos GG; Schilström B; Svensson TH
    J Neurosci Res; 1998 Mar; 51(5):583-92. PubMed ID: 9512002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subchronic and chronic PCP treatment produces temporally distinct deficits in attentional set shifting and prepulse inhibition in rats.
    Egerton A; Reid L; McGregor S; Cochran SM; Morris BJ; Pratt JA
    Psychopharmacology (Berl); 2008 May; 198(1):37-49. PubMed ID: 18427784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of acute and chronic lithium treatment on amphetamine-induced dopamine increase in the nucleus accumbens and prefrontal cortex in rats as studied by microdialysis.
    Baptista T; Teneúd L; Contreras Q; Burguera JL; Burguera M; Hernández L
    J Neural Transm Gen Sect; 1993; 94(2):75-89. PubMed ID: 7509157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Environmental enrichment attenuates locomotor sensitization, but not in vitro dopamine release, induced by amphetamine.
    Bardo MT; Bowling SL; Rowlett JK; Manderscheid P; Buxton ST; Dwoskin LP
    Pharmacol Biochem Behav; 1995; 51(2-3):397-405. PubMed ID: 7667360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolerance to neurochemical and behavioral effects of the hallucinogen 25I-NBOMe.
    Herian M; Skawski M; Wojtas A; Sobocińska MK; Noworyta K; Gołembiowska K
    Psychopharmacology (Berl); 2021 Aug; 238(8):2349-2364. PubMed ID: 34032876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amperozide, a novel antipsychotic drug, inhibits the ability of d-amphetamine to increase dopamine release in vivo in rat striatum and nucleus accumbens.
    Ichikawa J; Meltzer HY
    J Neurochem; 1992 Jun; 58(6):2285-91. PubMed ID: 1349347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.